Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 15/20 | 0.64 |
| ▸ | CTSL | P07711 | 3/20 | 0.57 |
| ▸ | CTSS | P25774 | 3/20 | 0.57 |
| ▸ | CTSK | P43235 | 3/20 | 0.57 |
| ▸ | CTSH | P09668 | 1/20 | 0.57 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29978571 | 0.89 | CXCR4 (0.59) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30307184 | 0.86 | CXCR4 (0.56) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30808876 | 0.86 | CTSL (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30275583 | 0.85 | CXCR4 (0.62) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31556101 | 0.85 | CXCR4 (0.64) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31607206 | 0.85 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29380582 | 0.84 | CXCR4 (0.64) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL7326493 | 0.84 | CXCR4 (0.68) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL6041189 | 0.84 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30381291 | 0.84 | KISS1R (0.56) | CXCR4CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113005166-B | Cod polypeptide with xanthine oxidase inhibitory activity | 中国海洋大学 | 2022-08-16 | — | — | CN | claimed |
| CN-113005166-B | Cod polypeptide with xanthine oxidase inhibitory activity | 中国海洋大学 | 2022-08-16 | — | — | CN | disclosed |